PRObing The Efficacy of Commercial Stage Storage Buffers and Evaluating Gut Metaproteome Variability Between Individuals
Launched by UNIVERSITY OF VIENNA · May 15, 2024
Trial Information
Current as of February 18, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well different storage solutions, called buffers, can preserve human gut fecal samples over time. Researchers want to find out if these buffers can keep proteins in the samples stable, which is important for understanding the gut microbiome—the community of microorganisms living in our intestines. By comparing these buffers to samples that are frozen immediately, the study hopes to establish better methods for preserving these samples for future research. Additionally, the trial will look at how much protein variability exists between different individuals, which can help improve the reliability of gut microbiome studies.
To participate in this trial, you need to be between 18 and 70 years old and willing to sign a consent form. However, if you have taken antibiotics in the last month or have had gastrointestinal surgery, you won't be eligible. If you join the study, you can expect to provide fecal samples periodically, and your contributions will help advance our understanding of gut health. This research is important because it aims to create standardized practices that could make future gut microbiome studies more accurate and comparable across different people and studies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • agreeing to participate after signing the informed consent form and
- • being 18-70 years old.
- Exclusion Criteria:
- • take antibiotics during the previous 1 month
- • had undergone gastrointestinal surgery
Trial Officials
Giacomo Carta, PhD
Principal Investigator
University of Vienna
About University Of Vienna
The University of Vienna, a leading research institution in Europe, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and cutting-edge research methodologies, the university aims to enhance patient care and public health outcomes. Its clinical trial programs are designed to address critical healthcare challenges by evaluating new therapies and interventions, contributing to the evidence-based practice of medicine. Through rigorous ethical standards and a commitment to scientific excellence, the University of Vienna plays a pivotal role in shaping the future of healthcare research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, Wien, Austria
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0